This is the authors' abstract. We don't add key points for this paper.
Most thyroid carcinoma (TC) is nonmedullary TC (NMTC), and papillary TC (PTC) constitutes about 85% of this group. Approximately 5% of TC patients have a similarly affected first-degree relative, suggesting a high degree of NMTC heritability (1). However, other potential explanations for this apparent familial association include environmental risk factors such as ionizing radiation. Ascertainment bias may contribute to this apparent familial association, since the thyroid gland is easily evaluated by both physical examination and ultrasound, and small (<1 cm) PTC are quite common in the older population (2). In this issue of the Journal of Clinical Endocrinology and Metabolism, Zayed et al test the hypothesis that genetic risk factors predispose to PTC by using an approach that minimizes the previously described potential confounders. Since PTC genetic risk factors might be recessive or dose dependent, the authors reasoned that consanguinity would be more frequent in PTC patients. Performing their study in Jordan, where consanguinity is relatively common, they found that for PTC patients the parental consanguinity prevalence was 25.5%, about twice that of 12.2% found in an unselected sample of healthy subjects. Individuals in this relatively small geographic area might have a similar exposure to radiation or other environmental risk factors. This approach also avoids ascertainment bias due to clinical investigation of first-degree relatives of affected subjects. In summary, this study by Zayed et al minimizes the potential confounders of other studies and provides further evidence to support the hypothesis that heritable factors predispose to PTC. A detailed understanding of the potential germline genetic alterations that predispose to NMTC is likely to lead to improved outcomes. Given the availability of powerful genetic analyses techniques, it might seem likely that the clues to this inherited susceptibility would be easily uncovered. In contrast, genetic NMTC predisposition is a complex jigsaw puzzle. Small sections of the big picture are beginning to emerge. These are divided into 3 groups: NMTC as a minor component of known familial cancer syndromes (syndromic NMTC), highly penetrant gene mutations, and polygenic inheritance (3). Is it possible that the studies of NMTC in consanguineous populations, such as those initiated by Zayed et al, may ultimately lead to the identification of autosomal recessive risk alleles and polygenic risk factors? NMTC is a relatively minor component of known familial tumor syndromes. These syndromes and the gene involved include familial adenomatous polyposis (APC), Cowden syndrome (PTEN), Dicer 1 syndrome (DICER1), and Carney complex (PRKAR1A) (3). However, the frequency of NMTC is too rare within these very rare syndromes to account for a significant portion of NMTC heritability. With Mendelian-inherited disorders, the investigation of large multigeneration kindreds has led to identification of the pathogenic gene mutations. The investigation of large NMTC kindreds have suggested that familial NMTC has a younger age of onset and may be slightly more aggressive than sporadic NMTC. Unfortunately, large NMTC kindreds are quite rare. As a result, this approach has met with only limited success, and potential highly penetrant gene mutations that have been identified are unique to a single or very few kindreds. As a recent example, He et al present evidence from a single large kindred that a germline truncating mutation of the TERF-1-interacting nuclear factor 2 gene (TINF2) is associated with longer telomeres and predisposition to both PTC and melanoma (4). This group, led by Dr. de la Chapelle, has had a number of successes applying whole-genome sequencing to NMTC kindreds and recently reported 40 gene variants of interest in 17 NMTC kindreds (5). These highly penetrant gene mutations are too rare to account for a substantial portion of NMTC heritability. Given the high degree of NMTC heritability and the relative paucity of large multigeneration kindreds, a number of authors have hypothesized that ≥ 2 DNA polymorphisms of low penetrance may interact with each other to increase NMTC risk (6). Liyanarachchi et al analyzed 3 sets of genome-wide association studies (GWAS) and identified 10 relatively common single nucleotide polymorphisms (SNPs) that are in linkage disequilibrium with NMTC in individuals of European descent. Those individuals carrying all 10 risk SNPs have approximately a 7-fold increased NMTC risk as compared to individuals carrying a single risk SNP. They estimate that these 10 risk SNPs account for about 10% of NMTC heritability (6). This represents a much greater part of the puzzle but still leaves the majority of NMTC heritability unexplained. It would be of interest to know if the consanguinity positive PTC patients of Zayed et al carry more of these risk SNPs than the consanguinity negative PTC patients. The failure of GWAS analyses to predict a greater degree of NMTC heritability may be due to pathogenic variants that are in regions of low linkage disequilibrium, rare variants that are overlooked in GWAS studies (6), or indolent undetected NMTC. The study by Zayed et al may open a previously unexplored path to the investigation of NMTC heritability. The increased frequency of consanguinity in the NMTC subjects is consistent with inheritance of recessive variants. Homozygosity mapping is a powerful method for identifying recessive variants and possibly modifier and interacting variants of complex disorders that may include regions coding for long noncoding RNAs and microRNAs (7). Consanguineous populations may be useful substrates for the identification of genetic variants predisposing to NMTC. In summary, NMTC is more highly heritable than most malignancies. GWAS studies and the application of whole-genome sequencing to the available kindreds have identified potential candidates that predispose to NMTC. Zayed et al present consanguinity data that further substantiates a familial predisposition to NMTC. Genetic analyses of consanguineous NMTC subjects may lead to the identification of different and important risk variants. Disclosures: The authors have nothing to disclose. Data sharing is not applicable to this article as no data sets were generated or analyzed during the current study.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Carl D. Malchoff (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: